Back to Directory

Herta Crauwels

Email

hcrauwel@its.jnj.com

Phone

(+32) 14 641-054

Institution

Janssen Infectious Diseases, BVBA

Title

Associate Director, Clinical Pharmacology

Address

Turnhoutseweg 30
2340 Beerse
,
Belgium

Request an Update

Affiliated Studies

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

IMPAACT 2017: MOCHA

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine

DAIDS Number

Research Area

Study Status

IMPAACT 2029: Phase I/II Study of Switching to Fixed Dose Combination Dolutegravir/Rilpivirine among Virologically Suppressed Children and Adolescents Living with HIV

DAIDS Number

Research Area

Study Status